In the present application, two hypotheses concerning the immune mechanisms that protect mice against vaginal infection by virus will be tested. Hypothesis 1: Specific antibodies of the IgA and IgG isotypes in the vaginal lumen contribute to immunity to HSV-2.
Aim 1 is to characterize and measure the concentrations of IgA and IgG antibodies in the vaginal lumen of normal and immune mice by immunoblotting and ELISA.
Aim 2 is to demonstrate that antibodies extracted from vaginal mucus of immune mice can neutralize HSV-2 at their concentrations in situ.
Aim 3 is to clarify the role of secretory IgA in vaginal immunity using IgA knockout mice.
Aim 4 is to determine whether vaginal immunization with attenuated HSV-2 causes long-term recruitment of IgG plasma cells to the vagina, local production of IgG, and increased specific IgG titers in vaginal secretions relative to parenteral immunization. Hypothesis 2: Recirculating memory lymphocytes in the vagina contribute to immunity to HSV-2; upon stimulation by challenge virus in the vagina, these cells release interferons that inhibit virus replication in the epithelium.
Aim 5 is to demonstrate and characterize lymphoid cell migration from the vaginal epithelium to the draining iliac lymph nodes.
Aim 6 is to demonstrate that T lymphocytes play a role in immunity to vaginal infection using in vivo depletion of T lymphocyte subsets.
Aim 7 is to measure the concentrations of interferons and tumor necrosis factor-alpha in vaginal mucus and demonstrate that they play a role in immunity to vaginal infection by depletion in vivo.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD017337-15
Application #
2888875
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Kaufman, Steven
Project Start
1983-09-01
Project End
2001-08-31
Budget Start
1999-09-01
Budget End
2001-08-31
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Southern Illinois University Carbondale
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
939007555
City
Carbondale
State
IL
Country
United States
Zip Code
62901
Parr, Margaret B; Parr, Earl L (2003) Vaginal immunity in the HSV-2 mouse model. Int Rev Immunol 22:43-63
Parr, M B; Parr, E L (2000) Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice. Immunology 101:126-31
Parr, M B; Parr, E L (2000) Interferon-gamma up-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and recruits lymphocytes into the vagina of immune mice challenged with herpes simplex virus-2. Immunology 99:540-5
Parr, M B; Parr, E L (1999) The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology 258:282-94
Parr, E L; Parr, M B (1999) Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunology 98:639-45
Parr, M B; Harriman, G R; Parr, E L (1998) Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice. Immunology 95:208-13
Parr, E L; Bozzola, J J; Parr, M B (1998) Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus. J Reprod Immunol 38:15-30
Parr, M B; Parr, E L (1998) Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J Virol 72:2677-85
Parr, E L; Parr, M B (1998) Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2. J Virol 72:5137-45
Parr, E L; Parr, M B (1997) Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J Virol 71:8109-15

Showing the most recent 10 out of 33 publications